Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy ...

Hims & Hers (HIMS) stock jumps as the company plans to launch cheaper compounded versions of Novo Nodisk's (NVO) Wegovy pill.

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy.

Lawmakers are warning Americans to beware the many financial scams linked to Super Bowl LX, from fake betting sites to ...

Hims & Hers is an asset-light platform. Subscriptions, cross-selling, and personalization drive rising ARPU, strong retention, and improving unit economics with structurally low CAC. Growth has ...

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $32.34, moving +2.05% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.16% for the ...

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 3.23% on an annualized basis producing an average annual return of 15.61%. Currently, Hims & Hers Health has a ...

The FTC is warning taxpayers to keep an eye out for phishing and smishing scams aimed at stealing tax refunds and personal data.

By Jonathan Stempel NEW YORK, Jan 29 (Reuters) - The founder of First Brands has been indicted by federal prosecutors for ...